
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:og="http://opengraphprotocol.org/schema/"
      xmlns:fb="http://www.facebook.com/2008/fbml">
<head>
    <script type="text/javascript" src="http://www.reuters.com/reuters_bootstrap.js"></script>
    <script type="text/javascript" src="http://www.reuters.com/reuters_gpt_bootstrap.js"></script>
    <!-- AdBlock Plus Begin-->
    <script type="text/javascript">var abp;</script>
    <script type="text/javascript" src="http://www.reuters.com/resources_v2/js/px.js?ch=1"></script>
    <script type="text/javascript" src="http://www.reuters.com/resources_v2/js/px.js?ch=2"></script>
    <!-- AdBlock Plus End-->

    <title>
        Pfizer bets $14 bln it knows better than market            </title>
    <meta property="fb:app_id" content="1446663712275737" />
    <meta property="og:title" content="Pfizer bets $14 bln it knows better than market"/>
    <meta property="og:site_name" content="Reuters" />
    <meta property="og:image" content="http://blogs.reuters.com/breakingviews//files/2016/08/or_8_pfizer4.jpg" />
    <meta property="og:url" content="http://blogs.reuters.com/breakingviews/2016/08/22/pfizer-bets-14-bln-it-knows-better-than-market/" />
    <meta property="og:description" content="The drug giant is paying a 120 pct premium for Medivation. It&#039;s a good fit and the biotech&#039;s cancer blockbuster is a rare gem. The whopping premium suggests Pfizer sees something others missed. But a heated auction and back-of-the-envelope math hint that the buyer is overpaying." />
    <meta name="SEARCH.BLOG_NAME" content="Breakingviews"/>
    <meta property="og:type" content="article" />
    <meta name="SEARCH.BLOG_NAME" content="Breakingviews"/>
    <meta name="CREATION_DATE" content="2016-08-22 7:14:26 " />

    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:site" content="@Reuters">
    <meta http-equiv="Content-type" content="text/html;charset=UTF-8" />

    <!-- Webtrends Meta Data -->
    <meta name="DCSext.rChannel" content="Blogs" />
    <meta name="DCSext.rCountry" content="US" />

    <meta name="WT.cg_n" content="Blogs - Breakingviews" />
    <meta name="WT.cg_s" content="Breakingviews" />
    <meta name="DCSext.ContentType" content="Blog Post" />
    <meta name="DCSext.ContentChannel" content="Breakingviews" />
    <meta name="WT.ti" content="Pfizer bets $14 bln it knows better than market - Breakingviews" />
    <meta name="DCSext.ContentHeadline" content="Pfizer bets $14 bln it knows better than market - Breakingviews" />

    <meta name="DCSext.DartZone" content="us.reuters/opinion/breakingviews/article" />


    <meta name="DCSext.rAuthor" content="Robert Cyran" />
    <meta name="SEARCH.AUTHOR" content="Robert Cyran" />
    <!-- End of Webtrends Meta Data -->


    <link rel="shortcut icon" href="http://www.reuters.com/resources_v2/images/favicon.ico" />
    <link rel="alternate" type="application/rss+xml" title="Breakingviews RSS Feed" href="http://blogs.reuters.com/breakingviews/feed/" />

    <script src="http://www.reuters.com/resources_v2/js/libraries/yui_2_7_0/yahoo/yahoo-min.js" type="text/javascript"></script>
    <script src="http://www.reuters.com/resources_v2/js/libraries/yui_2_7_0/event/event-min.js" type="text/javascript"></script>
    <script src="http://www.reuters.com/resources_v2/js/libraries/yui_2_7_0/dom/dom-min.js" type="text/javascript"></script>
    <script src="http://www.reuters.com/resources_v2/js/libraries/yui_2_7_0/yahoo-dom-event/yahoo-dom-event.js" type="text/javascript"></script>
    <script src="http://www.reuters.com/resources_v2/js/libraries/yui_2_7_0/animation/animation-min.js" type="text/javascript"></script>
    <script src="http://www.reuters.com/resources_v2/js/libraries/yui_2_7_0/connection/connection-min.js" type="text/javascript"></script>
    <script src="http://www.reuters.com/resources_v2/js/rcom-agent.js" type="text/javascript"></script>

    <script src="http://www.reuters.com/resources_v2/js/libraries/yui_2_7_0/cookie/cookie-min.js" type="text/javascript"></script>

    <script src="http://www.reuters.com/resources_v2/js/libraries/jquery-1.11.1.min.js" type="text/javascript"></script>
    <script src="http://www.reuters.com/resources_v2/js/libraries/jquery-migrate-1.2.1.min.js" type="text/javascript"></script>
    <!-- DO NOT EDIT OR REMOVE THIS CODE -->
    <link href="http://www.reuters.com/resources_v2/css/rcom-main.css" rel="stylesheet" />
    <link href="http://www.reuters.com/resources_v2/css/rcom-section.css" rel="stylesheet" />
    <link href="http://www.reuters.com/resources_v2/css/rcom-navigation.css" rel="stylesheet" />
    <!--    <link href="http://www.reuters.com/resources_v2/css/rcom-blogs.css" rel="stylesheet" /> -->
    <link rel="stylesheet" href="http://blogs.reuters.com/breakingviews/wp-content/themes/reuters-blogs-2014/style.css" type="text/css" media="screen" />
    <link rel="stylesheet" href="http://blogs.reuters.com/breakingviews/wp-content/themes/reuters-blogs-2014/rcom-share.css" type="text/css"/>
    <link rel="alternate" type="application/rss+xml" title="Breakingviews &raquo; Pfizer bets $14 bln it knows better than market Comments Feed" href="http://blogs.reuters.com/breakingviews/2016/08/22/pfizer-bets-14-bln-it-knows-better-than-market/feed/" />
    <script type="text/javascript">
			window._wpemojiSettings = {"baseUrl":"http:\/\/s.w.org\/images\/core\/emoji\/72x72\/","ext":".png","source":{"concatemoji":"http:\/\/blogs.reuters.com\/breakingviews\/wp-includes\/js\/wp-emoji-release.min.js?ver=4.2.5"}};
			!function(a,b,c){function d(a){var c=b.createElement("canvas"),d=c.getContext&&c.getContext("2d");return d&&d.fillText?(d.textBaseline="top",d.font="600 32px Arial","flag"===a?(d.fillText(String.fromCharCode(55356,56812,55356,56807),0,0),c.toDataURL().length>3e3):(d.fillText(String.fromCharCode(55357,56835),0,0),0!==d.getImageData(16,16,1,1).data[0])):!1}function e(a){var c=b.createElement("script");c.src=a,c.type="text/javascript",b.getElementsByTagName("head")[0].appendChild(c)}var f,g;c.supports={simple:d("simple"),flag:d("flag")},c.DOMReady=!1,c.readyCallback=function(){c.DOMReady=!0},c.supports.simple&&c.supports.flag||(g=function(){c.readyCallback()},b.addEventListener?(b.addEventListener("DOMContentLoaded",g,!1),a.addEventListener("load",g,!1)):(a.attachEvent("onload",g),b.attachEvent("onreadystatechange",function(){"complete"===b.readyState&&c.readyCallback()})),f=c.source||{},f.concatemoji?e(f.concatemoji):f.wpemoji&&f.twemoji&&(e(f.twemoji),e(f.wpemoji)))}(window,document,window._wpemojiSettings);
		</script>
    <style type="text/css">
img.wp-smiley,
img.emoji {
	display: inline !important;
	border: none !important;
	box-shadow: none !important;
	height: 1em !important;
	width: 1em !important;
	margin: 0 .07em !important;
	vertical-align: -0.1em !important;
	background: none !important;
	padding: 0 !important;
}
</style>
    <link rel='stylesheet' id='abuse-css'  href='http://blogs.reuters.com/breakingviews/wp-content/mu-plugins/comment-abuse/abuse.css?v=3&#038;ver=4.2.5' type='text/css' media='all' />
    <link rel='stylesheet' id='dashicons-css'  href='http://blogs.reuters.com/breakingviews/wp-includes/css/dashicons.min.css?ver=4.2.5' type='text/css' media='all' />
    <link rel='stylesheet' id='thickbox-css'  href='http://blogs.reuters.com/breakingviews/wp-includes/js/thickbox/thickbox.css?ver=4.2.5' type='text/css' media='all' />
    <link rel='canonical' href='http://blogs.reuters.com/breakingviews/2016/08/22/pfizer-bets-14-bln-it-knows-better-than-market/' />
    <!--START: Reuters Registration-->
    <!--<script language="JavaScript" type="text/javascript" src="https://commerce.us.reuters.com/login/js/auth_plugin.js"></script>-->
    <script language="JavaScript" type="text/javascript" src="https://commerce.us.reuters.com/login/js/auth_plugin.js?flow=COMMENTS"></script>
    <!--script language="JavaScript" type="text/javascript" src="http://blogs.reuters.com/breakingviews/wp-content/plugins/reuters-registration/js/jquery-1.3.2.min.js"></script-->
    <script language="JavaScript" type="text/javascript" src="http://blogs.reuters.com/breakingviews/wp-content/plugins/reuters-registration/js/jqModal.js"></script>
    <script language="JavaScript" type="text/javascript" src="http://blogs.reuters.com/breakingviews/wp-content/plugins/reuters-registration/js/reuters-registration.js?v=2009120103"></script>
    <!--END: Reuters Registration-->
    <!-- Vipers Video Quicktags v6.5.2 | http://www.viper007bond.com/wordpress-plugins/vipers-video-quicktags/ -->
    <style type="text/css">
.vvqbox { display: block; max-width: 100%; visibility: visible !important; margin: 10px auto; } .vvqbox img { max-width: 100%; height: 100%; } .vvqbox object { max-width: 100%; }
</style>
    <script type="text/javascript">
// <![CDATA[
	var vvqflashvars = {};
	var vvqparams = { wmode: "opaque", allowfullscreen: "true", allowscriptaccess: "always" };
	var vvqattributes = {};
	var vvqexpressinstall = "http://blogs.reuters.com/breakingviews/wp-content/plugins/vipers-video-quicktags/resources/expressinstall.swf";
// ]]>
</script>
    <script type="text/javascript">
 window._taboola = window._taboola || [];
 _taboola.push({article:'auto'});
 !function (e, f, u) {
    e.async = 1;
    e.src = u;
    f.parentNode.insertBefore(e, f);
  }(document.createElement('script'), document.getElementsByTagName('script')[0], 'http://cdn.taboola.com/libtrc/reuters-network/loader.js');
</script>


</head>
<body>
<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-W9SLGS"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push(
{'gtm.start': new Date().getTime(),event:'gtm.js'}
);var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-W9SLGS');</script>
<!-- End Google Tag Manager -->
<!--googleoff: index-->
<div id="loginbox" class="jqmWindow"></div>

<script type="text/javascript" src="http://www.reuters.com/resources_v2/js/rcom-header-widget.js"></script>

<div class="section" id="blogsBannerStrip">
    <div id="div_gpt_lb">
        <div class="ad" id="leaderboard">
            <script type="text/javascript">
                                            displayAd_sync("us.reuters/opinion/breakingviews/article");

                </script>
        </div>
    </div>
</div><div id="content" class="post postsingle blogs">
    <div class="section gridlined8">

        <div class="sectionContent">
            <div id="sectionHeader">
                <div id="preamble">
                    <a href="http://blogs.reuters.com/breakingviews" title="Breakingviews">Breakingviews</a>
                </div>
            </div>

            <div class="sectionColumns">
                <div class="column1 gridPanel grid8">
                    <!--googleon: index-->
                    <div class="module" id="post-37581">
                        <div class="moduleBody">
                            <div class="">
                                <div class="columnRight grid8" id="single">
                                    <h2>Pfizer bets $14 bln it knows better than market</h2>
                                    <div id="thebyline">
                                        <div class="author">
                                            By <a href="http://www.reuters.com/journalists/robert-cyran/">Robert Cyran</a>			</div>
                                        <div class="timestamp">August 22, 2016</div>
                                    </div>
                                    <div class="reuters-share reuters-share-color"
                                         data-share-short-url="http://reut.rs/2bJcaJj"
                                         data-share-url="http://blogs.reuters.com/breakingviews/2016/08/22/pfizer-bets-14-bln-it-knows-better-than-market/"
                                         data-share-title="Pfizer bets $14 bln it knows better than market"
                                         data-share-desc="The drug giant is paying a 120 pct premium for Medivation. It's a good fit and the biotech's cancer blockbuster is a rare gem. The whopping premium suggests Pfizer sees something others missed. But a heated auction and back-of-the-envelope math hint that the buyer is overpaying. "
                                         data-share-img="http://blogs.reuters.com/breakingviews//files/2016/08/or_8_pfizer4.jpg"
                                         data-share="twitter,facebook,linkedin,reddit,google,mail"
                                         data-share-count="false"></div>
                                    <div class="posttags">
                                        <h5 class="tags">Tags:</h5> <a href="http://blogs.reuters.com/breakingviews/tag/ma">M&amp;A</a> | <a href="http://blogs.reuters.com/breakingviews/tag/pharmaceuticals">pharmaceuticals</a> | <a href="http://blogs.reuters.com/breakingviews/tag/u-s">U.S.</a>	</div>
                                    <div id="postcontent"><p><em>The author is a Reuters Breakingviews columnist. The opinions expressed are his own. </em></p>
                                        <p>Pfizer seems to know something others don’t about Medivation. It’s betting $14 billion on the biotech, a 120 percent premium to the undisturbed market value. It’s a good fit and Medivation’s cancer blockbuster is a rare gem. But a heated auction and back-of-the-envelope math hint that the buyer is overpaying.</p>
                                        <p>Big drug companies are always on the lookout for new drugs to sell. Among the most appealing are cancer therapies with fat margins. The concentrated market means few salespeople are needed, and drugs with a proven benefit over rival treatments can command sky-high prices. Medivation’s Xtandi for prostate cancer costs well over $100,000 per year.</p>
                                        <p>Worldwide sales of Xtandi were $595 million in the second quarter. Even this gem has flaws, however. Pfizer will have to share rights to the drug with Japanese company Astellas Pharma. Medivation currently receives half of U.S. profits and a royalty from overseas sales.</p>
                                        <p>Despite these limitations, Pfizer is paying more than 11 times Medivation’s estimated sales for 2017. The market values Pfizer at 4.5 times its revenue. There are big caveats to this comparison, but at the very least it suggests that Pfizer expects sales to grow sharply in future years. Yet Xtandi’s U.S. sales are leveling off, with growth running at an 11 percent annual rate in the second quarter. Extending treatment with the drug and expanding into new cancers may boost growth again, but that remains to be proven.</p>
                                        <p>Redemption might come from Medivation’s potential drug for breast and other cancers. The company’s management recently said the new category of cancer treatment concerned could produce sales of $30 billion a year, with its drug capturing a big chunk. That sounds like part of the company’s sales pitch, though. Medivation paid just $410 million for it a year ago, with a promise of up to another $160 million as approvals are achieved. Analysts are mostly projecting annual sales of around $300 million from this drug.</p>
                                        <p>Pfizer may believe in a far more lucrative outcome. But it also had to outbid multiple savvy rivals including Astellas, Medivation’s natural partner, and Sanofi. The most probable explanation for the heady price is that Pfizer has once again paid more than it should have done.</p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="navigationB">
                        <div class="alignleft">
                            <div class="nav-link-text">
                                &laquo; Previous Post

                            </div>
                            <div class="nav-link-title"><a href="http://blogs.reuters.com/breakingviews/2016/08/22/britains-haul-27-gold-medals-and-a-wooden-spoon/" rel="prev">Britain’s haul: 27 gold medals and a wooden spoon</a> </div>
                        </div>
                        <div class="alignright">
                            <div class="nav-link-text">
                                Next Post &raquo;
                            </div>
                            <div class="nav-link-title"><a href="http://blogs.reuters.com/breakingviews/2016/08/23/microfinance-leaves-indias-banks-in-the-dust/" rel="next">Microfinance leaves India&#8217;s banks in the dust</a> </div>
                        </div>
                    </div>

                    <div style="clear:both"></div>

                    <div class="bizDevTop">
                        <div class="bizDevTopLeft">
                            <div id='taboola-bmc'></div>
                            <script type="text/javascript">
                                        window._taboola = window._taboola || []; _taboola.push({mode:'organic-text-links-2c', container:'taboola-bmc', placement:'bmc', target_type:'text'});
                                        </script>
                        </div>
                        <div class="bizDevTopRight" style="margin-top: 10px; border-top: 2px solid #333;">
                            <iframe valign="middle" width="300" height="295" marginheight=0 marginwidth=0 frameborder=0 vspace=0 hspace=0 scrolling=NO  src="http://www.smartlinks.dianomi.com/smartads.epl?id=1734"></iframe>
                        </div>
                    </div>
                    <div class="bizDevBottom">
                        <div id='taboola-below-main-column'></div>
                        <script type="text/javascript">
                                window._taboola = window._taboola || [];
                                _taboola.push({mode:'thumbs-2r', container:'taboola-below-main-column', placement:'below-main-column'});
                                </script>
                    </div>

                    <div style="clear:both"></div>

                    <!--googleoff: index-->
                    <a name="comments"></a>
                    <div class="articleComments postcomment">
                        <div class="gridPanel grid8"><div class="commentsHeader">No comments so far</div></div>

                        <div class="comment-form-container">
                            <a name="commentform"></a>
                            <div id="pendingstatus"></div>
                            <div id="loginstatus"></div>
                            <form action="http://blogs.reuters.com/breakingviews/wp-content/plugins/reuters-registration/comments-post.php" method="post" id="commentform">
                                <p><textarea onclick="javascript:rr_checkLogin();" name="comment" id="comment" style="width: 610px;" cols="80" rows="10" tabindex="4"></textarea></p>

                                <p><input name="submit" type="submit" id="submit" tabindex="5" value="Submit Comment" />
                                    <input type="hidden" name="comment_post_ID" value="37581" />
                                </p>
                                <p style="display: none;"><input type="hidden" id="akismet_comment_nonce" name="akismet_comment_nonce" value="3ddfb7bbf6" /></p><p style="display: none;"><input type="hidden" id="ak_js" name="ak_js" value="194"/></p>
                            </form>

                            <div class="disclaimer">
                                <p>We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see <a href="http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/">http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/</a></p>
                            </div>
                        </div>


                        <!-- Comment page numbers -->
                        <!-- End comment page numbers -->
                    </div>

                    <div>
                        <!--googleon: index-->
                        <!--googleoff: index-->
                    </div>
                </div>
                <div class="column2 gridPanel grid4">
                    <div id="sidebar" class="rhsidebar">
                        <ul id="adBugTop">
                            <li id="text-12" class="widget widget_text">			<div class="textwidget"></div>
                            </li><li class="widggap"></li>                </ul>
                        <ul>
                            <li id="authorsidebar-3" class="widget widget_authorsidebar"><div class="module"><div class="moduleHeader"><h3>Author Profile</h3></div><ul>
                                <li class="authorprofile">
                                    <a href="/robertcyran/"><img src="/wp-content/profile-images/rtr_upe_cr_1991-profile-image.jpg" alt="Robert Cyran" style="border: 0px;"/></a>
                                    <div class="authorprofilebio">
                                        Robert Cyran, U.S. tech columnist, joined Breakingviews in London in 2003 and moved four years later to New York, where he continues to cover global technology, pharmaceuticals and special situations. Robert began his career at Forbes magazine, where he assisted in the start-up of the international version of the magazine. Before working at Breakingviews he worked as a market researcher and reporter covering the pharmaceutical industry. Robert has a Masters degree in economics from Birmingham University and an undergraduate degree from George Washington University.          </div>
                                    <div class="authordisclaimer">Any opinions expressed here are the author's own.</div>
                                </li>
                            </ul>
                                <div class="clear"></div></div></li><li class="widggap"></li><li id="reutersmpu-10" class="widget widget_reutersmpu"><div class="module">                <div class="mpu" id="div_gpt_mpu">
                            <script type="text/javascript">
                                                    displayAd("div_gpt_mpu", "us.reuters/opinion/breakingviews/article", "[300,250]", "type=mpu");

                    </script>
                        </div>
                            <div class="clear"></div></div></li><li class="widggap"></li><li id="rsspie-4" class="widget RSSpie_Widget"><div class="module"><div class="moduleHeader"><h3>Breakingviews Video</h3></div><ul class="mod-videos"><li>        <a href="http://www.reuters.com/video/2016/08/23/breakingviews-viacoms-interim-drama?videoId=369645112&amp;feedType=VideoRSS&amp;feedName=Breakingviews&amp;videoChannel=117766" class="mod-video-image"><img src="http://yospace-cds1.reuters.com/u/resize~ad1~120x120/0/f/~image_jpeg~9999-2/1/m/0/b/d/v/u15s/reuters04?videoId=121538213" alt=""></a>        <h3><a href="http://www.reuters.com/video/2016/08/23/breakingviews-viacoms-interim-drama?videoId=369645112&amp;feedType=VideoRSS&amp;feedName=Breakingviews&amp;videoChannel=117766">Breakingviews: Viacom's interim drama</a></h3>        <p>The best reason to keep longtime exec Tom Dooley beyond September is to sell off the media company's assets to the highest bidders. Jen Saba and Rob Cox discuss.</p></li><li>        <a href="http://www.reuters.com/video/2016/08/19/breakingviews-inter-generational-strife?videoId=369634902&amp;feedType=VideoRSS&amp;feedName=Breakingviews&amp;videoChannel=117766" class="mod-video-image"><img src="http://yospace-cds1.reuters.com/u/resize~ad1~120x120/0/f/~image_jpeg~9999-2/1/m/f/w/x/5/f55u/reuters04?videoId=121439737" alt=""></a>        <h3><a href="http://www.reuters.com/video/2016/08/19/breakingviews-inter-generational-strife?videoId=369634902&amp;feedType=VideoRSS&amp;feedName=Breakingviews&amp;videoChannel=117766">Breakingviews: Inter-generational strife</a></h3>        <p>Kevin Allison and Richard Beales debate some of the realities – and myths – of the wealth gap between baby boomers and millennials, and what can be done to close it.</p></li><li>        <a href="http://www.reuters.com/video/2016/08/19/breakingviews-viacom-on-wall-street?videoId=369616793&amp;feedType=VideoRSS&amp;feedName=Breakingviews&amp;videoChannel=117766" class="mod-video-image"><img src="http://yospace-cds1.reuters.com/u/resize~ad1~120x120/0/f/~image_jpeg~9999-2/1/m/w/7/g/2/a9rx/reuters04?videoId=121435086" alt=""></a>        <h3><a href="http://www.reuters.com/video/2016/08/19/breakingviews-viacom-on-wall-street?videoId=369616793&amp;feedType=VideoRSS&amp;feedName=Breakingviews&amp;videoChannel=117766">Breakingviews: Viacom on Wall Street</a></h3>        <p>Antony Currie and Jennifer Saba argue the TV company needs to invest in new content or get into the M&A game now CEO Philippe Dauman is gone. That'll bring investment bankers flocking.</p></li>
                        </ul><div class="clear"></div></div></li><li class="widggap"></li><li id="text-9" class="widget widget_text"><div class="module"><div class="moduleHeader"><h3>Breakingviews Books</h3></div>			<div class="textwidget"><div class="mod-books">
                            <p class="mod-books-disclaimer">Breakingviews has published a selection of books for purchase and download. </p>
                            <div class="mod-books-section">
                                <div class="mod-books-image">
                                    <img src="http://blogs.reuters.com/breakingviews/files/2016/01/breakingviewspredictionscoverfinal.jpg" width="90" height="121" />
                                </div>
                                <div class="contentBook">
                                    <h3><a href="http://bvpredictions.com/">PREDICTIONS 2016: STAIRWAY TO HEAVEN, HIGHWAY TO HELL</a></h3>
                                    <p>Edited by Reynolds Holding</p>
                                    <p><a href="http://bvpredictions.com/">Read Online</a></p>
                                    <p><a href="http://fingfx.thomsonreuters.com/gfx/breakingviews/1/19/19/PredictionsPDF.pdf">Download PDF</a></p>
                                    </p></div>
                                </p></div>
                            <div class="mod-books-section">
                                <div class="mod-books-image">
                                    <img src="http://blogs.reuters.com/breakingviews/files/2015/08/breakingviews-atamerlion.jpg" width="90" height="121" />
                                </div>
                                <div class="contentBook">
                                    <h3><a href="http://bitly.com/BreakingviewsSingapore50">A TAMER LION: SINGAPORE AT 50</a></h3>
                                    <p>Edited by Peter Thal Larsen and Quentin Webb</p>
                                    <p><a href="http://bitly.com/BreakingviewsSingapore50">Read Online</a></p>
                                    <p><a href="http://bit.ly/BreakingviewsSingapore50PDF">Download PDF</a></p>
                                    </p></div>
                                </p></div>
                            <div class="mod-books-section">
                                <div class="mod-books-image">
                                    <img src="http://blogs.reuters.com/breakingviews/files/2015/01/predictions.jpg" width="90" height="121" />
                                </div>
                                <div class="contentBook">
                                    <h3><a href="http://fingfx.thomsonreuters.com/2014/12/30/025734a1d4.pdf">Predictions 2015: Animal Spirits and Crisis Ghosts</a></h3>
                                    <p>Edited by Richard Beales</p>
                                    <p><a href="http://bit.ly/BreakingviewsPredictions2015Mobile">View on mobile device</a></p>
                                    </p></div>
                                </p></div>
                            <div class="mod-books-section">
                                <div class="mod-books-image">
                                    <img src="http://blogs.reuters.com/breakingviews/files/2014/09/breakingviews-alibababook.jpg" width="90" height="121" />
                                </div>
                                <div class="contentBook">
                                    <h3>Alibaba and the twelve digits</h3>
                                    <p>By Peter Thal Larsen</p>
                                    <p><a href="http://bit.ly/BreakingviewsAlibaba">Read the e-book online</a></p>
                                    <p><a href="http://bit.ly/BreakingviewsAlibabaPDF">Download PDF (English)</a></p>
                                    <p><a href="http://bit.ly/BreakingviewsAlibabaPDFChinese">Download PDF (Chinese) (点击下载电子书)</a></p>
                                    <p><a href="http://www.breakingviews.com/home/alibaba-ipo/">Visit the dedicated webpage (Breakingviews subscribers only)</a></p>
                                    </p></div>
                                </p></div>
                            <div class="mod-books-section">
                                <div class="mod-books-image">
                                    <img src="http://blogs.reuters.com/breakingviews/files/2014/05/TechMania.jpg" width="90" height="121" />
                                </div>
                                <div class="contentBook">
                                    <h3><a href="http://reut.rs/TechMania">Tech Mania 2014</a></h3>
                                    <p>Edited by Robert Cyran</p>
                                    <p><a href="http://bit.ly/BreakingviewsPredictions2015Mobile">View on mobile device</a></p>
                                    </p></div>
                                </p></div>
                            <div class="mod-books-section">
                                <div class="mod-books-image">
                                    <img src="http://blogs.reuters.com/breakingviews/files/2014/01/predictions2014.png" width="90" height="121" />
                                </div>
                                <div class="contentBook">
                                    <h3><a href="http://link.reuters.com/wug75v">Predictions 2014: Reversals and Revivals</a></h3>
                                    <p>Edited by John Foley</p>
                                    </p></div>
                                </p></div>
                        </div>
                        </div>
                            <div class="clear"></div></div></li><li class="widggap"></li><li id="reutersmpu-11" class="widget widget_reutersmpu"><div class="module">                <div class="mpu" id="div_gpt_mpulow">
                            <script type="text/javascript">
                                                    displayAd("div_gpt_mpulow", "us.reuters/opinion/breakingviews/article", "[300,250]", "type=mpulow");

                    </script>
                        </div>
                            <div class="clear"></div></div></li><li class="widggap"></li><li id="text-8" class="widget widget_text"><div class="module">			<div class="textwidget"><a class="twitter-timeline" data-dnt="true" href="https://twitter.com/Breakingviews" data-widget-id="479404315316998145">Tweets by @Breakingviews</a>
                            <script>!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs");</script></div>
                            <div class="clear"></div></div></li><li class="widggap"></li><li id="text-7" class="widget widget_text"><div class="module">			<div class="textwidget"><script type="text/javascript">
TR3.insertBussUnit("http:\/\/ad.doubleclick.net\/N4735792\/adj\/us.reuters;type=BizDev_Blogs_RR1;sz=300x1");
</script>
                            <style>
    .mod-about,
    .mod-books,
    .mod-videos{
        font-size: 10px;
    }
    .mod-about p,
    .mod-books p,
    .mod-videos p{
        font-size: 14px;
        margin-bottom 5px;
    }
    .mod-videos h3,
    .mod-books h3{
        font-size: 16px;
        line-height: 16px;
        margin-bottom: 10px;
    }
</style></div>
                            <div class="clear"></div></div></li><li class="widggap"></li>            </ul>
                    </div>
                </div>
            </div>
        </div>
    </div>
    <!--/div One div too many I believe -->
    <script type="text/javascript" src="http://www.reuters.com/resources_v2/js/rcom-footer-widget.js"></script>

    <script type="text/javascript">doBlogsLoginMenu();</script><script type='text/javascript' src='http://blogs.reuters.com/breakingviews/wp-content/plugins/akismet/_inc/form.js?ver=3.1.5'></script>
    <!-- Page generated by blogs.reuters.com: 48 queries. 0.413 seconds. -->
    <script type="text/javascript">
var _baq = _baq || [];
_baq.push(['setClientId','DIZ5C3']);
_baq.push(['trackPageView']);
(function () {
    var s = document.createElement('script');
    s.src = ('https:' == document.location.protocol ?
    'https://commerce.us.reuters.com' :
    'http://mediacdn.reuters.com')
    + '/pulse/2/trb.js';
    (document.getElementsByTagName('HEAD')[0] ||
    document.getElementsByTagName('BODY')[0]).appendChild(s);
}());
</script>
    <script type="text/javascript">
  window._taboola = window._taboola || [];
  _taboola.push({flush:true});
</script>

    <script type='text/javascript'>
        var _sf_startpt=(new Date()).getTime();
        var _sf_async_config={};

        _sf_async_config.uid = 52639;
        _sf_async_config.domain = 'reuters.com';
        _sf_async_config.sections = 'Breakingviews';
        _sf_async_config.type = 'Blogs';
                _sf_async_config.authors = 'Robert Cyran';
        _sf_async_config.path = 'blogs.reuters.com/breakingviews/2016/08/22/pfizer-bets-14-bln-it-knows-better-than-market/';


        (function(){
          function loadChartbeat() {
            window._sf_endpt=(new Date()).getTime();
            var e = document.createElement('script');
            e.setAttribute('language', 'javascript');
            e.setAttribute('type', 'text/javascript');
            e.setAttribute('src', '//static.chartbeat.com/js/chartbeat.js');
            document.body.appendChild(e);
          }
          var oldonload = window.onload;
          window.onload = (typeof window.onload != 'function') ?
             loadChartbeat : function() { oldonload(); loadChartbeat(); };
        })();
    </script>

</body>
</html>



<!-- Dynamic page generated in 0.409 seconds. -->
<!-- Cached page generated by WP-Super-Cache on 2016-08-24 13:09:33 -->
<!-- Compression = gzip -->